BELLINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 630
EU - Europa 584
AS - Asia 190
SA - Sud America 3
Totale 1407
Nazione #
US - Stati Uniti d'America 628
CN - Cina 156
UA - Ucraina 150
GB - Regno Unito 133
IT - Italia 85
DE - Germania 73
SE - Svezia 53
FI - Finlandia 37
TR - Turchia 31
FR - Francia 25
GR - Grecia 19
BE - Belgio 5
CA - Canada 2
CL - Cile 2
IN - India 2
AR - Argentina 1
IE - Irlanda 1
JP - Giappone 1
NL - Olanda 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 1407
Città #
Jacksonville 222
Chandler 58
Ann Arbor 48
Woodbridge 48
Beijing 47
Princeton 39
Medford 35
Caserta 34
San Mateo 30
Wilmington 24
Dearborn 21
Nanjing 20
Kunming 14
Roxbury 11
Auburn Hills 10
Jinan 10
Cambridge 9
Düsseldorf 9
Hefei 9
Des Moines 7
Los Angeles 7
Napoli 6
Redwood City 6
Brussels 5
Guangzhou 5
Hebei 5
Houston 5
Nanchang 5
Shanghai 5
Hangzhou 4
Mountain View 4
Ningbo 4
Venice 4
Zhengzhou 4
Centrale 3
Falls Church 3
Shenyang 3
Ashburn 2
Bologna 2
Brusciano 2
Changchun 2
Chongqing 2
Fairfield 2
Hampstead 2
Lanzhou 2
Lissone 2
Milan 2
Norwalk 2
Santiago 2
Voghera 2
Xian 2
Bloomington 1
Budenheim 1
Catanzaro 1
Changsha 1
Dallas 1
Elora 1
Fiano Romano 1
Florence 1
Fremont 1
Fuzhou 1
Groningen 1
Harbin 1
Huzhou 1
Jiaxing 1
Livorno 1
Melrose 1
Merlo 1
Nanning 1
Ottawa 1
Sacramento 1
Salerno 1
Sant'anastasia 1
Teano 1
Tianjin 1
Tokyo 1
Wenzhou 1
Yinchuan 1
Totale 838
Nome #
null 71
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 60
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats. 51
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease 50
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. 50
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 49
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 48
The A1 adenosine receptor as a new player in microglia physiology 45
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. 43
Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model. 43
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. 42
EP1 receptor within the ventrolateral periaqueductal grey controls thermonociception and rostral ventromedial medulla cell activity in healthy and neuropathic rat 42
TNF-α effect on human delivery onset by CB1/TRPV1 crosstalk: new insights into endocannabinoid molecular signaling in preterm vs. term labor. Analysis of the EC/EV pathway and predictive biomarkers for early diagnosis of preterm delivery 42
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions 39
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. 39
Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat 38
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 38
The 17-estradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression 38
Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties. 38
Benign Familial Neonatal Seizures 37
Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice 35
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. 35
A mutation (V260M) in the middle of the M2 pore-lining domain of the glycine receptor causes hereditary hyperekplexia 33
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 33
Hyperekplexia caused by dominant-negative suppression of glyra1 function 32
A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists 32
Neutralization of a unique, negatively-charged residue in the voltage sensor of K V 7.2 subunits in a sporadic case of benign familial neonatal seizures 32
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 32
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 31
A novel mutation (R218Q) at the boundary between the N-terminal and the first transmembrane domain of the glycine receptor in a case of sporadic hyperekplexia 30
No evidence for association between dyslexia and DYX1C1 functional variants in a group of children and adolescents from Southern Italy. 29
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 29
Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy 28
La presenza della variante Q63 del recettore dei cannabinoidi (CB2) si associa ad un più severa epatonecrosi nei pazienti con epatite cronica C. 28
EXCLUSION DE LINKAGE A 8Q24 DANS UNE FAMILLE AVEC ABSENCE DE L'ENFANCE A DEBUT PRECOCE ET TOLERANCE REDUITE AU VPA 27
Familial occurrence of early-onset childhood absence epilepsy 26
Benign Familial Neonatal Seizures . In: editors. Seattle (WA): Apr 27 26
null 26
Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor 21
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption 14
Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C 8
The CB2-63 RR variant is an independent predictor of severe liver necroinflammation in chronic hepatitis B 3
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 2
Totale 1495
Categoria #
all - tutte 2397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018112 00045 82 425 12466
2018/2019139 471111 469 284 6742
2019/2020403 433947 5230 10451 3224107
2020/2021341 3705014 585 4534 2513015
2021/2022292 33306 913 106 6522062
2022/2023103 4831168 00 00 0000
Totale 1495